YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY
Dilantin Can Cause Stevens Johnson Syndrome and Toxic Necrolysis Syndrome, Potentially Deadly Skin Diseases
According to class action lawsuits filed against Pfizer, the makers of Dilantin, the drugs have caused severe skin diseases caused by and allergic reaction.
If you or a family member has taken Dilantin and have been injured, you may be entitled to compensation.
- Our firm is vigorously pursuing this matter.
- Our clients have received millions of dollars in lawsuits involving defective drugs.
- No Charge or Obligation for Our Experienced Attorney Review
CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its
Dilantin (generic: phenytoin) is a commonly prescribed medication used to treat epilepsy and seizures. Dilantin was approved by the FDA in 2001. Since then there have been numerous reports of severe side effects affecting the skin. A major side effect is Stevens Johnson Syndrome (SJS), a potentially deadly skin disease which produces burn-like rashes, open sores and skin peeling. SJS is deadly between 5%-15% of the time. The drug has also been linked to Toxic Necrolysis Syndrome (TENS) which is deadly in 30%-40% patients. The side effects to these severe skin diseases include:
- Flu-like symptoms (fever, sore throat, cough)
- Red or purple skin rash
- Blisters on the skin or mucous membranes, especially in the mouth, nose and eyes
- Facial swelling
- Tongue swelling
- Skin pain
- Skin shedding
Those taking Dilantin may also face cellulitis, sepsis, eye problems which can lead to blindness, internal organ damage and permanent skin damage. These side effects can last a lifetime.
Plaintiffs in class action lawsuits claim Pfizer, and the generic drug makers Mylan Pharmaceuticals and Baxter Healthcare, were aware of the drugs dangers but failed to adequately warn the public about the increased risks of the severe skin diseases.